Effectiveness of Nasal-alar Elevator Combined With Taping Vs. Taping Alone on Improving the Nose Esthetics and Maxillary Arch Dimensions in Infants With Unilateral Complete Cleft Lip and Palate

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT04331379
Collaborator
(none)
32
1
2
17.7
1.8

Study Details

Study Description

Brief Summary

This randomized trial is designed to assess the effectiveness of nasal elevator as a presurgical infant orthopedics on improvement of nose esthetics vs taping alone.

Condition or Disease Intervention/Treatment Phase
  • Device: Nasal Elevator
  • Device: Taping Alone
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
32 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effectiveness of Nasal-alar Elevator (NE) Combined With Taping Vs. Taping Alone on Improving the Nose Esthetics and Maxillary Arch Dimensions in Infants With Unilateral Complete Cleft Lip and Palate: A Randomized Clinical Trial
Actual Study Start Date :
Jul 9, 2020
Actual Primary Completion Date :
Dec 30, 2021
Actual Study Completion Date :
Dec 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Nasal Elevator

Device: Nasal Elevator
A device aiming to elevate the clefted nostril extraorally and fixed on the forehead.

Active Comparator: Taping Alone

Device: Taping Alone
Horizontal tape alone.

Outcome Measures

Primary Outcome Measures

  1. Nasal Esthetics [3 months]

    Nasal esthetics will be following Dr Farkas' measurements and it will be carried out as linear and angular measurements on standardized photographs. it will be measured using photoshop software.

  2. Maxillary arch changes [3 months]

    Different maxillary arch dimensions (e.g. cleft and arch widths and symmetry) will be measured virtually on digital models in mm using 3shape software.

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Day to 30 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Infants with age range from 1-30 days.

  • Unilateral complete cleft lip and alveolus.

  • Medically free subjects.

  • Both males and females.

  • Cleft gap more than 10 mm.

Exclusion Criteria:
  • Patients older than 30 days.

  • Syndromic patients with other defects in addition to cleft lip and palate.

  • Patients with bilateral cleft lip and palate.

  • Incomplete Cleft lip.

  • Patient with previous surgical lip repair or adhesion.

  • Patients with previous presurgical infant orthopedic treatment.

  • Medically compromised patients.

  • Cleft gap distance less than 10mm

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Dentistry Giza Egypt 00202

Sponsors and Collaborators

  • Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mohamed Abd El-Ghafour, Lecturer of Orthodontics, Cairo University
ClinicalTrials.gov Identifier:
NCT04331379
Other Study ID Numbers:
  • 111
First Posted:
Apr 2, 2020
Last Update Posted:
Mar 10, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 10, 2022